Feeds
Pharmacy benefits manager Express Scripts Inc. said Wednesday that it is suing Walgreen Co., arguing the drugstore chain is trying to lure away its customers.
Walgreen Co. said that it is willing to walk away from more than $5 billion in annual revenue because pharmacy benefits manager Express Scripts Inc. doesn't pay it enough to fill prescriptions.
Walgreen Co. said that it is willing to walk away from more than $5 billion in annual revenue because pharmacy benefits manager Express Scripts doesn't pay it enough to fill prescriptions.
A study published Wednesday says hospitals and the federal government could save tens of billions of dollars a year if they changed the way group purchasing organizations — which buy medical supplies in bulk for member hospitals — are compensated.
Rite Aid Corp. said Tuesday it will add discount groceries to some of its stores in South Carolina as it tests out a partnership with Supervalu Inc.
Hemispherx Biopharma has been awarded a $188 million judgment against a South African investment firm that tried to take over the company using false information.
Shares of PDL BioPharma Inc. plunged Friday on word of a royalty dispute between PDL and its collaborator Genentech.
Economists say the U.S. recovery continued during the second quarter of this year with more businesses hiring workers and fewer cutting jobs, but the pace of growth has slowed, a new survey shows.
NEW YORK — Medicare administrators say they will take a full year to review Dendreon Corp.'s prostate cancer therapy Provenge and decide whether to cover the costly treatment.
Shares of InterMune crashed in premarket trading Wednesday after regulators asked the company to perform additional tests on its lung disease drug Esbriet, potentially delaying its approval by years.
Genzyme Corp. said Wednesday it fell to a first-quarter loss as sales declined and the biotech drugmaker set aside $175 million to pay a government fine related to manufacturing problems at its Allston, Mass., plant.
Pharmacy benefits manager Medco Health Solutions Inc. said even though its CEO took a 7 percent pay cut in 2009, he still received $13.3 million in total compensation, according to Associated Press calculation of figures filed with regulators.
The CEO of Botox maker Allergan Inc. received compensation valued at $11.1 million in 2009, according to an Associated Press calculation of figures filed with regulators. That was a drop of 18 percent from 2008.
Cytori Therapeutics Inc. said Friday it received approval to sell its PureGraft system, which can remove fat tissue from a patient and prepare it for re-injection in about 15 minutes.
Walgreen Co. says shoppers bought fewer holiday items in December compared with a year earlier, and it carried fewer seasonal products, both of which weakened a key sales measure for the drugstore chain.
The president and CEO of drug distributor AmerisourceBergen Corp. received a compensation package valued at $5.5 million in 2009, up 3 percent from the year before, according to Associated Press calculation of figures filed with regulators Tuesday.
CVS Caremark Corp. on Monday took another step toward combining its drug benefit management services with patients' genetic profiles, as it hired the president of genetic benefits manager Generation Health to lead its struggling Caremark business.
Cubist Pharmaceuticals Inc. said Thursday it stopped enrolling patients in trials of a drug intended to reduce bleeding during heart surgery because of deaths among patients that took it.
High-speed analog chipmaker Inphi Corp. said Monday it is suing server and storage systems maker Netlist Inc. for patent infringement.
Shares of digital mammogram system maker Hologic Inc. fell Tuesday after a government task force recommended that women wait longer before having mammograms, and have the breast examinations less often.
Alkermes Inc. said a late stage clinical trial shows its drug Vivitrol, which is used to help alcoholics quit drinking, also helped opioid addicts stay off drugs.
Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about half of patients who did not respond to standard treatments.
Drugmaker Pfizer Inc. said Thursday its shareholders will have input on compensation for company executives starting in 2010.
Investors appear cautious ahead of AGA Medical Holdings Inc.'s initial public offering scheduled for Wednesday, as the potential blockbuster heart devices the company is developing are several years from reaching the market.
The CEO of Cardinal Health Inc. received compensation worth $10 million in fiscal 2009, an increase of 2 percent from the previous year due to a bigger stock and options award, according to an Associated Press calculation of figures filed with regulators.
Log In | Register
